简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
the Gold Equities ETF
Spot gold tops USD 5,200/oz for first time, Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF (517520) surges almost 8% in early trade
Tags:
ETF
the Gold Equities ETF
517520.SH
2026-01-28
Institution: Non-ferrous metals shine as dollar weakens; Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF (517520) up 0.67% in early trade, aiming for third straight gain
Tags:
ETF
517520.SH
the Gold Equities ETF
2026-01-27
Spot gold tops USD 5,000/oz,Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF (517520) surges more than 6% in early trade
Tags:
the Gold Equities ETF
517520.SH
ETF
2026-01-26
Institution: Gold is experiencing a powerful resurgence of its financial attributes,Maxwealth CSI Shanghai-Shenzhen-Hong Kong Gold Industry Commodity ETF(517520) gains nearly 4% in early trade
Tags:
517520.SH
ETF
the Gold Equities ETF
2026-01-23
Featured News
Finance
Estun (02715.HK): Positive Profit Forecast, Interim Net Profit Attributable to Parent Expected to Surge Around 21 to 26 Times
Finance
CHINA DEVELOPMENT BANK FINANCIAL LEASING(01606.HK): Acquisition of Three Vessels at Consideration Not Exceeding USD 138 Million
Finance
Holly Futures(03678.HK): Independent Director Zhang Hongfa Resigns
Finance
Shenwan Hongyuan (06806.HK): Shenwan Hongyuan Securities Obtains Registration Approval for Perpetual Subordinated Bonds with a Ceiling of RMB 30 Billion
Finance
Luxxu Group(01327.HK): Executive Director Yang Xi Resigns; Liang Yanhuang Appointed as Authorised Representative
Finance
United Laboratories (03933.HK): New Specification of Sodium Hyaluronate Eye Drops Approved for Marketing
Finance
Dongjiang Environmental (00895.HK): 2026 Interim Performance Forecast, Expected Net Loss of RMB 250 Million to RMB 270 Million
Finance
CSPC Pharmaceutical Group (01093.HK): Albumin-Bound Docetaxel Combined with Anitumab Granted Breakthrough Therapy Designation
Finance
China Everbright Water (01857.HK): Completes Issuance of Phase 1 Medium-Term Notes of 2026 with Principal of RMB 1.5 Billion
Finance
MicroTech Medical(02235.HK): Continuous Glucose Monitoring System Secures Marketing Approval in South Korea
Scan QR Code
Download App